Cannabis Law Report

APRIL 21, 2022

MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

JUNE 6, 2022

Patients expect their pharmacists to know how cannabis interacts with their medications and conditions. About the Skaggs School of Pharmacy and Pharmaceutical Sciences. During its 110-year history, the School of Pharmacy has been a global leader in medical discoveries, patient care, pharmacy advocacy, and online education.

Education 52

Education Research and Development Pharmaceutical Programs 52

Cannabis Law Report

OCTOBER 14, 2021

formerly the Canadian Association of Retired Persons), Canada’s largest advocacy association for Canadians As We Age. Understanding the utility of medical cannabis is increasingly important to older Canadians for the treatment of conditions including chronic pain, anxiety and lack of sleep. ’s advocacy.

Advocacy 52

Advocacy Research and Development Chronic Pain Pharmaceutical 52

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Cannabis Law Report

JUNE 26, 2019

I am a medical patient in Florida’s Medical Marijuana Use Registry due my qualifying condition: a 2010 diagnosis of aggressive Multiple Sclerosis. I used to be a pharmaceutical statistic of opiate and controlled substance pain medications, alongside 25 other Multiple Sclerosis symptom-fighting medications for seven long years.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Healing Advocacy Fund. in/carhart-harris-robin-19112542/ [link]. David Nutt. Drug Science.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Spasticity from neurological conditions. Background. Conclusions.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. Nikki’s story is deeply inspirational, and we are honored to have had her on the show.

Patients 83

Patients Compliance Compliance Cannabis 83

Cannabis Law Report

JULY 30, 2019

Patients carefully consider a choice of cannabis physician based on their personal past health, their qualifying condition, and their current health needs: essentially, patients decide which physician can serve that patient’s needs by adding cannabis as a therapeutic medication. .

Marijuana 45

Marijuana Patients Research and Development Programs 45

The Cannigma

DECEMBER 8, 2021

Then from there, you can get them to, “Okay, it can help with a variety of medical conditions.” EG: So, at that time, through your treatment, were you using cannabis? I think one thing that really comes to mind for me, this qualified condition. Then maybe you can get them to the point of, “Okay, it’s fine for medical.

Access 81

Access Policy Patients Cannabis 81

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

SEPTEMBER 10, 2019

Instead, CBD is fast garnering a reputation in the medical world as a potentially soothing treatment for conditions like arthritis, epilepsy , mental stress, or muscle pain, even as for certain forms of cancer.). (Don’t confuse CBD with THC! That’s the chemical in cannabis with the psychoactive effects. Bankers turning to cannabis.

CBD 45

CBD Wellness and Beauty Banking Epilepsy 45

The Cannigma

DECEMBER 22, 2021

At the moment, you said that they could potentially add more conditions. What conditions, or indications can doctors prescribe for in Israel at the moment? IR: Well, today, there is a closed list, basically, of conditions. It also doesn’t include doctor education and research into different conditions.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

NORML

FEBRUARY 8, 2019

Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. Legislation is pending, House Bill 2687, to protect medical cannabis patients who require organ transplants from being deprived treatment solely due to their status as a medical cannabis patient.

Legislation 173

Legislation Decriminalization Patients Access 173

The Cannigma

MAY 7, 2021

In Europe, Murphy explains, cannabis products are held to the same standards of accountability and repeatability as other pharmaceuticals. What do those more pharmaceutical standards mean for patients? MSO: Obviously, every country is different but within Europe and certain rainy islands close to it.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

APRIL 22, 2019

The TGA’s Traveller’s Exemption allows travellers and their carers to bring up to three months worth of prescribed therapeutic goods for medical treatment into the country which would otherwise be listed as non-controlled substances. Gaining access to the medication, however, can take up to several months.

Chronic Pain 10

Chronic Pain Medicine Conditions Access 10

Cannabis Law Report

SEPTEMBER 22, 2019

Knowing Your Rights , provided by the national medical cannabis advocacy organization Americans for Safe Access, admonishes current cannabis consumers: Medical cannabis patients and their providers are vulnerable to federal and state raids, arrest, prosecution, and incarceration. PERSONAL RIGHTS.

Cannabis 45

Cannabis Access Patients Legalization 45